Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Cardiology · Myocardial Infarction with Non-Obstructive Coronary Arteries

What Happens After a MINOCA Heart Attack Diagnosis?

At a Glance

After a MINOCA heart attack, an angiogram showing no major blockage is only a starting point. Cardiologists use an echocardiogram, cardiac MRI, and sometimes artery or rhythm testing to find the cause, then tailor medicines and follow-up to support recovery and reduce future risk.

In this answer

3 sections

01

Finding the True Cause

02

Tailoring Your Treatment Plan

03

Recovery and Follow-Up

MINOCA stands for Myocardial Infarction with Non-Obstructive Coronary Arteries. This means you meet the medical criteria for having a heart attack, but your angiogram shows that your major coronary arteries are not severely blocked (typically defined as having less than 50% blockage) [1].

Because your major arteries are open, MINOCA is not a final explanation. Instead, it is a “working diagnosis”—it confirms a heart injury has occurred, but the exact mechanism is still hidden [2]. The immediate next step is to investigate exactly why the heart muscle was injured, followed by adjusting your treatment to target that specific cause [3].

Important Safety Warning: If you experience new or worsening chest pressure, severe shortness of breath, fainting, or sustained racing heartbeats after being discharged, call local emergency services immediately. Do not drive yourself to the hospital. Furthermore, do not stop taking any of your prescribed discharge medications (especially antiplatelet or anticoagulant medicines) without explicit instructions from your care team.

Finding the True Cause

Because standard angiograms only look at the large surface arteries of the heart, they can miss underlying issues. Not everyone needs every test; your cardiologist will select the safest and most useful tests based on your clinical stability, symptoms, and the initial angiogram findings [4].

  • Echocardiogram: This ultrasound looks at how your heart beats and pumps [5]. It can help identify unusual wall-motion patterns that provide early clues about the underlying problem [6].
  • Cardiac MRI (CMR): This is a highly informative imaging test for suspected MINOCA. While it is often most useful when performed within the first 1 to 2 weeks, a scan done later can still provide valuable information [7][8]. A CMR provides detailed pictures of the heart tissue and helps distinguish a true ischemic heart attack from conditions that mimic one, such as myocarditis (inflammation of the heart muscle) or Takotsubo syndrome (a temporary heart dysfunction that can happen with or without an obvious emotional trigger) [9][10].
  • Intravascular Imaging (OCT or IVUS): In carefully selected cases, tiny cameras or ultrasound probes are threaded inside the artery during an angiogram [11]. These tools can spot microscopic cracks in the artery wall (plaque rupture or erosion) or Spontaneous Coronary Artery Dissection (SCAD), which is a hidden tear in the inner lining of the blood vessel [4][12].
  • Coronary Functional Testing: If the physical structure of the arteries looks normal, a specialized team may test how the arteries function by injecting specific medications during an angiogram [13]. This helps detect coronary vasospasm (arteries suddenly squeezing shut) or microvascular dysfunction (problems with the tiny blood vessels that feed the heart) [14][15].
  • Embolism Testing: Sometimes a blood clot travels to the coronary artery from elsewhere (an embolism). Your team may use rhythm monitoring to look for irregular heartbeats (like atrial fibrillation) or special echocardiograms to check for blood clots in the heart chambers or valves [16][17].

Tailoring Your Treatment Plan

Patients with suspected MINOCA are often treated initially with standard acute coronary syndrome medications while the cause is being clarified [3]. Once the specific mechanism is found, your care team will adjust your long-term plan [4]:

  • Plaque Disruption: If tests reveal a microscopic plaque crack, you will likely be treated with standard heart attack medications, including statins and antiplatelet medicines [18][19].
  • Vasospasm: If your arteries are squeezing shut, first-line therapy typically involves medications like calcium-channel blockers or nitrates, which keep the blood vessels relaxed [20][21].
  • Spontaneous Coronary Artery Dissection (SCAD): SCAD is often managed with careful medical monitoring, as the artery may heal on its own [22]. However, stenting is sometimes necessary if you have ongoing chest pain, poor blood flow, or other high-risk features [23].
  • Embolism: If a traveling clot caused the heart attack, your team will focus on preventing future clots, which may require anticoagulants [24].

Note on Blood Thinners: Antiplatelet medicines (like aspirin or clopidogrel) prevent blood cells called platelets from clumping together. Anticoagulants (like apixaban or warfarin) slow down the body’s chemical clotting process. Both medications work differently, and both increase your risk of bleeding, so they must be used exactly as prescribed [18].

While some observational studies suggest that medications like statins or ACE inhibitors might be associated with better outcomes in certain MINOCA populations, this does not mean every patient should take them [25][26]. Medications must be specifically chosen based on the underlying mechanism, your heart’s pumping function, and your personal risk factors [27].

Recovery and Follow-Up

Leaving the hospital with a normal-looking angiogram does not mean the event was harmless or that no follow-up is needed. A clear follow-up plan is vital. Your post-discharge care should include:

  • A scheduled review with your cardiologist to discuss test results, especially if you are waiting on a Cardiac MRI or rhythm monitoring.
  • A discussion about whether you are a candidate for cardiac rehabilitation, a medically supervised program that helps improve heart health [26].
  • Individualized guidance on when it is safe to return to work, exercise, and daily activities.

Common questions in this guide

Can I really have a heart attack if my coronary arteries are not badly blocked?
Yes. MINOCA means tests show heart muscle injury meeting the criteria for a heart attack even though the main coronary arteries do not have a severe blockage, usually less than 50% narrowing. It is a working diagnosis, so more testing is needed to determine the cause.
Which tests help doctors find the cause of MINOCA?
An echocardiogram can show how well the heart pumps and whether particular areas move abnormally. Cardiac MRI can distinguish an ischemic heart attack from myocarditis or Takotsubo syndrome. Depending on the findings, doctors may use imaging inside the artery, blood-vessel function tests, rhythm monitoring, or specialized echocardiography; not everyone needs every test.
When is the best time to have a cardiac MRI after MINOCA?
A cardiac MRI is often most informative when performed within the first one to two weeks after the event. A later scan can still provide useful information, so timing depends on your stability, symptoms, and cardiologist’s recommendation.
How is treatment chosen after the cause of MINOCA is found?
Many patients initially receive medicines used for acute coronary syndrome while the evaluation continues. Treatment is then matched to the cause: statins and antiplatelet medicine may be used for plaque disruption, calcium-channel blockers or nitrates for artery spasm, and anticoagulants when a traveling clot caused the event. A coronary artery dissection may be monitored closely and sometimes treated with a stent if blood flow or symptoms are concerning.
What is the difference between antiplatelet drugs and anticoagulants?
Antiplatelet medicines keep blood platelets from clumping together, while anticoagulants interfere with the body’s chemical clotting process. They work differently, and either can increase bleeding risk, so do not start, stop, or change them without instructions from your care team.
Which symptoms after discharge mean I should call emergency services?
Call local emergency services immediately for new or worsening chest pressure, severe shortness of breath, fainting, or a sustained racing heartbeat. Do not drive yourself, and do not stop prescribed antiplatelet or anticoagulant medicines unless your care team tells you to.
What follow-up should I plan after a MINOCA heart attack?
Arrange a cardiology review to discuss pending cardiac MRI, rhythm monitoring, and other test results. Ask whether cardiac rehabilitation is appropriate and when it is safe to return to work, exercise, and daily activities. A normal-looking angiogram does not eliminate the need for follow-up.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

Heart Attack Fatigue: How Long and When Is Activity Safe? How Long Can Troponin Stay High After a Heart Attack? Missed Antiplatelet Dose After a Heart Attack or Stent? Is Bruising Normal on Dual Antiplatelet Therapy After MI? How Do I Care for My Catheter Site After an Angiogram?
Show more
Should I Chew Aspirin for a Suspected Heart Attack? Are Palpitations After a Heart Attack Dangerous? Monitoring When Is an ICD Considered After a Heart Attack with Low EF? What Are Heart Failure Warning Signs After a Heart Attack? What Does LVEF Mean After a Heart Attack? Explained How Are Mental Health Symptoms Treated After a Heart Attack? How Do I Prevent Stent Thrombosis and Restenosis After MI? Does Type 2 MI Need a Stent or the Same Medications? How Are Myocarditis and Takotsubo Unlike a Heart Attack? What Is SCAD and How Is a SCAD Heart Attack Treated? Why Are Heparin and Antiplatelets Both Used in PCI? Why Was I Given a Stent or Clot-Buster for My Heart Attack? What Happens During a Coronary Angiogram and Stent? What Mechanical Complications Follow a Heart Attack?

Get notified when new evidence is published on acute myocardial infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What findings currently support my working diagnosis of MINOCA, and which alternative diagnoses or 'mimics' still need to be ruled out?
  2. 2.If a Cardiac MRI is recommended, when is the best time for me to have it done to get the most accurate results?
  3. 3.What specific mechanism is suspected to have caused my heart attack, and do my current medications match that exact cause?
  4. 4.What are the specific bleeding risks associated with the antiplatelet or anticoagulant medicines I am taking?
  5. 5.How long should I expect to remain on each of the medications prescribed at discharge?
  6. 6.Based on the suspected cause of my MINOCA, is it safe for me to participate in a cardiac rehabilitation program?

References

References (27)
  1. 1

    Cardiovascular magnetic resonance in myocardial infarction with non-obstructive coronary arteries patients: A review.

    Gatti M, Carisio A, D'Angelo T, et al.

    World journal of cardiology 2020; (12(6)):248-261 doi:10.4330/wjc.v12.i6.248.

    PMID: 32774777
  2. 2

    Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA).

    Occhipinti G, Bucciarelli-Ducci C, Capodanno D

    European heart journal. Acute cardiovascular care 2021; (10(7)):813-822 doi:10.1093/ehjacc/zuab049.

    PMID: 34179954
  3. 3

    MINOCA: a heterogenous group of conditions associated with myocardial damage.

    Singh T, Chapman AR, Dweck MR, et al.

    Heart (British Cardiac Society) 2021; (107(18)):1458-1464 doi:10.1136/heartjnl-2020-318269.

    PMID: 33568434
  4. 4

    Diagnostic Advancements in MINOCA: Do They Translate to a Better Clinical Outcome? A Review of the Literature.

    Bozika M, Apostolos A, Nastouli KM, et al.

    Medicina (Kaunas, Lithuania) 2026; (62(7)) doi:10.3390/medicina62071243.

    PMID: 42512786
  5. 5

    Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions.

    Vidal-Perez R, Abou Jokh Casas C, Agra-Bermejo RM, et al.

    World journal of cardiology 2019; (11(12)):305-315 doi:10.4330/wjc.v11.i12.305.

    PMID: 31908730
  6. 6

    Editor's Choice- Pathophysiology, diagnosis and management of MINOCA: an update.

    Scalone G, Niccoli G, Crea F

    European heart journal. Acute cardiovascular care 2019; (8(1)):54-62 doi:10.1177/2048872618782414.

    PMID: 29952633
  7. 7

    Early versus late cardiac magnetic resonance in the diagnosis of myocardial infarction with non-obstructive coronary arteries.

    Macedo Conde I, Salazar M, Pereira VH, et al.

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2024; (43(7)):417-425 doi:10.1016/j.repc.2023.12.010.

    PMID: 38492801
  8. 8

    Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

    Sörensson P, Ekenbäck C, Lundin M, et al.

    JACC. Cardiovascular imaging 2021; (14(9)):1774-1783 doi:10.1016/j.jcmg.2021.02.021.

    PMID: 33865778
  9. 9

    The Role of Cardiac Magnetic Resonance in Myocardial Infarction and Non-obstructive Coronary Arteries.

    Liang K, Nakou E, Del Buono MG, et al.

    Frontiers in cardiovascular medicine 2021; (8()):821067 doi:10.3389/fcvm.2021.821067.

    PMID: 35111833
  10. 10

    Diagnostic and Prognostic Role of Cardiac Magnetic Resonance in MINOCA: Systematic Review and Meta-Analysis.

    Mileva N, Paolisso P, Gallinoro E, et al.

    JACC. Cardiovascular imaging 2023; (16(3)):376-389 doi:10.1016/j.jcmg.2022.12.029.

    PMID: 36889851
  11. 11

    Imaging patients with myocardial infarction with non-obstructive coronary arteries (MINOCA).

    Leo I, Bisaccia G, Miaris N, et al.

    Heart (British Cardiac Society) 2024; (110(3)):209-217 doi:10.1136/heartjnl-2023-322835.

    PMID: 37433660
  12. 12

    OCT Findings in MINOCA.

    Bryniarski K, Gasior P, Legutko J, et al.

    Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132759.

    PMID: 34201727
  13. 13

    The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA).

    Mangiacapra F, Viscusi MM, Paolucci L, et al.

    Frontiers in cardiovascular medicine 2021; (8()):781485 doi:10.3389/fcvm.2021.781485.

    PMID: 34869695
  14. 14

    Case report: assessment and management of myocardial infarction and non-obstructive coronary arteries (MINOCA): the role of microvascular coronary vasospasm.

    Marpuri R, Joung S, Gadh A, et al.

    Cardiovascular diagnosis and therapy 2019; (9(4)):400-405 doi:10.21037/cdt.2019.07.13.

    PMID: 31555546
  15. 15

    Coronary functional assessment in non-obstructive coronary artery disease: Present situation and future direction.

    Zhai C, Fan H, Zhu Y, et al.

    Frontiers in cardiovascular medicine 2022; (9()):934279 doi:10.3389/fcvm.2022.934279.

    PMID: 36082113
  16. 16

    OCT and CMR for the Diagnosis of Patients Presenting With MINOCA and Suspected Epicardial Causes.

    Gerbaud E, Arabucki F, Nivet H, et al.

    JACC. Cardiovascular imaging 2020; (13(12)):2619-2631 doi:10.1016/j.jcmg.2020.05.045.

    PMID: 32828786
  17. 17

    Role of cardiac magnetic resonance in MINOCA of unclear etiology: a case report of a suspicious paradoxical coronary embolism.

    Scabbia F, Zerbini M, Pirani L, et al.

    BJR case reports 2023; (9(1)):20220114 doi:10.1259/bjrcr.20220114.

    PMID: 36873233
  18. 18

    Myocardial ischemia in nonobstructive coronary arteries: A review of diagnostic dilemmas, current perspectives, and emerging therapeutic innovations.

    Seshadri H, Gunasekaran D, Mohammad A, et al.

    World journal of cardiology 2025; (17(5)):106541 doi:10.4330/wjc.v17.i5.106541.

    PMID: 40496390
  19. 19

    Precision medicine in Myocardial Infarction With Non-obstructive Coronary Disease (MINOCA): A comprehensive review.

    Fatima L, Goyal A, Yakkali S, et al.

    Current problems in cardiology 2024; (49(2)):102185 doi:10.1016/j.cpcardiol.2023.102185.

    PMID: 37925046
  20. 20

    Managing heart failure with reduced ejection fraction merged with myocardial infarction with non-obstructive coronary arteries: a case report.

    Ikebe S, Yamamoto M, Ishii M, et al.

    European heart journal. Case reports 2024; (8(10)):ytae540 doi:10.1093/ehjcr/ytae540.

    PMID: 39450321
  21. 21

    Repetitive catamenial myocardial infarction due to coronary artery spasm: a case report.

    Talmor N, Gurin M, Smilowitz N, et al.

    European heart journal. Case reports 2023; (7(2)):ytad019 doi:10.1093/ehjcr/ytad019.

    PMID: 36793935
  22. 22

    Spontaneous Coronary Artery Dissection: Pitfalls of Angiographic Diagnosis and an Approach to Ambiguous Cases.

    Adlam D, Tweet MS, Gulati R, et al.

    JACC. Cardiovascular interventions 2021; (14(16)):1743-1756 doi:10.1016/j.jcin.2021.06.027.

    PMID: 34412792
  23. 23

    Case Report: Spontaneous coronary artery dissection presenting as MINOCA in uncontrolled Graves' disease.

    Pan Y, Han H, Chen J, Zhang S

    Frontiers in cardiovascular medicine 2026; (13()):1885077 doi:10.3389/fcvm.2026.1885077.

    PMID: 42465536
  24. 24

    Coeliac Disease: A Rare Cause of Myocardial Infarction With Non-Obstructive Coronary Arteries.

    Leghlimi H, Chraibi H, Bendagha N, et al.

    Cureus 2023; (15(5)):e38469 doi:10.7759/cureus.38469.

    PMID: 37273318
  25. 25

    Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.

    De Filippo O, Russo C, Manai R, et al.

    International journal of cardiology 2022; (368()):1-9 doi:10.1016/j.ijcard.2022.08.034.

    PMID: 35987312
  26. 26

    Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.

    Lindahl B, Baron T, Erlinge D, et al.

    Circulation 2017; (135(16)):1481-1489 doi:10.1161/CIRCULATIONAHA.116.026336.

    PMID: 28179398
  27. 27

    Prognostic impact of secondary prevention medical therapy following myocardial infarction with non-obstructive coronary arteries: a Bayesian and frequentist meta-analysis.

    Samaras A, Papazoglou AS, Balomenakis C, et al.

    European heart journal open 2022; (2(6)):oeac077 doi:10.1093/ehjopen/oeac077.

    PMID: 36523547

This page is for informational purposes only and does not constitute medical advice about your MINOCA diagnosis. Your cardiologist must interpret your test results and medication plan; seek emergency care for new or worsening symptoms.